- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05385965
Meaning-Centered Pain Coping Skills Training for Cancer Pain (MCPC)
Meaning-Centered Pain Coping Skills Training: A Randomized Controlled Trial of a Psychosocial Intervention for Advanced Cancer Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Many patients with advanced cancer describe pain as a debilitating symptom that greatly interferes with activities they care about. Psychosocial interventions show promise for improving cancer-related pain; however, there is a lack of interventions that address existential and spiritual concerns (e.g., a loss of meaning, purpose, and peace) that are common among those facing high levels of pain interference from advanced cancer.
To address this need, an intervention called Meaning-Centered Pain Coping Skills Training (MCPC) was developed. In this trial, the investigators will randomize patients to MCPC or enhanced usual care control (target N = 210). Patient-reported outcomes will be assessed at baseline and 8- and 12-weeks after baseline. As in the investigators' extensive pilot work, MCPC's four 45-to-60 minute individual weekly sessions will be delivered by trained study therapists via an accessible videoconference format. Intervention sessions focus on training participants in evidence-based cognitive-behavioral skills, such as guided imagery and activity pacing. Emphasis is placed on using skills to reduce the degree to which pain interferes with participants' sense of meaning, purpose, and peace.
The first aim of this trial is to determine the efficacy of MCPC for reducing the primary outcome of pain interference at 8-weeks. The second aim is to determine the efficacy of MCPC for improving secondary outcomes at 8-weeks. The third aim is to test the maintenance of MCPC's effects on primary and secondary outcomes at 12-weeks. The fourth aim is to estimate the cost-effectiveness of implementing MCPC.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Stage IV solid tumor cancer diagnosis
- Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower
- At least one clinical pain severity rating > 0 out of 10 in past month
- At least moderate pain interference (8-item Patient-Reported Outcomes Measurement Information System [PROMIS] Pain Interference T-score >/= 55) in the past week at telephone screening
- Ability to speak and read in English
- Age >/= 18 years.
Exclusion Criteria:
- Significant cognitive impairment as indicated in medical chart or during telephone screening
- Serious untreated mental illness
- Primary brain cancer diagnosis
- Previous engagement in Pain Coping Skills Training or Meaning-Centered Psychotherapy
- Enrollment in hospice at screening
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Meaning-Centered Pain Coping Skills Training
Four, 45-60 minute, videoconference-delivered sessions focus on training participants in cognitive and behavioral skills (e.g., guided imagery, activity pacing) for managing pain.
|
The goal of this intervention is to help participants reduce pain interference so that they can engage with what gives them a sense of meaning, purpose, and peace.
|
|
No Intervention: Standard Care
Information and referrals for free services available through the Duke Cancer Patient Support Program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference-Short Form
Time Frame: 8-week follow-up
|
This 8-item measure assesses the degree to which, over the past 7 days, pain has interfered with daily activities, work around the home, engagement in social activities, household chores, fun activities, enjoyment of social activities, enjoyment of life, and family life.
Response options range from 1 (not at all) to 5 (very much).
Higher scores indicate worse pain interference.
|
8-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference-Short Form
Time Frame: 12-week follow-up
|
This 8-item measure assesses the degree to which, over the past 7 days, pain has interfered with daily activities, work around the home, engagement in social activities, household chores, fun activities, enjoyment of social activities, enjoyment of life, and family life.
Response options range from 1 (not at all) to 5 (very much).
Higher scores indicate worse pain interference.
|
12-week follow-up
|
|
Brief Pain Inventory-Short Form (BPI-SF) Pain Severity Subscale
Time Frame: 8-week follow-up and 12-week follow-up
|
This 4-item measure assesses pain severity at its worst, least, and average over the past 7 days as well as current pain severity.
Response options range from 0 (no pain) to 10 (pain as bad as you can imagine).
Higher scores indicate worse pain severity.
|
8-week follow-up and 12-week follow-up
|
|
Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp)
Time Frame: 8-week follow-up and 12-week follow-up
|
This 12-item measure references the past 7 days and includes an overall spiritual well-being score and three subscales: 1) meaning (i.e., reason for living, sense of meaning and purpose); 2) peace (i.e., feeling peaceful, sense of harmony within oneself); and 3) faith (i.e., finding strength and comfort in faith or spiritual beliefs).
Response options range from 0 (not at all) to 4 (very much); two items are reverse coded.
Higher scores indicate greater spiritual well-being.
|
8-week follow-up and 12-week follow-up
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Meaning and Purpose Scale
Time Frame: 8-week follow-up and 12-week follow-up
|
This 8-item measure assesses feelings of meaning and purpose, including having a good sense of what makes one's life meaningful, a sense that one's life is valuable and worthwhile, having clear goals and aims, feeling life one's life has meaning, significance, direction, fulfillment, and purpose.
Response options range from 1 (strongly disagree or not at all) to 5 (strongly agree or very much).
Higher scores indicate greater meaning and purpose.
|
8-week follow-up and 12-week follow-up
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety-Short Form
Time Frame: 8-week follow-up and 12-week follow-up
|
This 8-item measure assesses anxiety symptoms over the past 7 days, including fear, difficulty focusing on things other than anxiety, feeling overwhelmed by worries, feeling uneasy, nervousness, feeling the need for help with anxiety, feeling anxious, and feeling tense.
Response options range from 1 (never) to 5 (always).
Higher scores indicate worse anxiety.
|
8-week follow-up and 12-week follow-up
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression-Short Form
Time Frame: 8-week follow-up and 12-week follow-up
|
This 8-item measure assesses depressive symptoms over the past 7 days, including feelings of worthlessness, helplessness, hopelessness, depression, failure, unhappiness, nothing to look forward to, and difficulty improving mood.
Response options range from 1 (never) to 5 (always).
Higher scores indicate worse depressive symptoms.
|
8-week follow-up and 12-week follow-up
|
|
Chronic Pain Self-Efficacy Scale (CPS)
Time Frame: 8-week follow-up and 12-week follow-up
|
This 5-item measures assesses patients' confidence regarding pain management, managing pain during daily activities, keeping pain from interfering with sleep, and confidence in their ability to reduce pain using methods other than taking additional medication.
Response options range from 10 (not at all certain) to 100 (very certain).
Higher scores indicate greater self-efficacy.
|
8-week follow-up and 12-week follow-up
|
|
Medical Outcomes Study Social Support Survey (MOS-SS)
Time Frame: 8-week follow-up and 12-week follow-up
|
This 8-item measure assesses how often someone was available to provide instrumental (i.e., practical) support and emotional support.
Instrumental support includes having someone available if confided to bed, needing to visit a doctor, needing help preparing meals, and needing help with daily chores.
Emotional support includes having someone available to have a good time with, turn to for suggestions, feel understood, and feel loved and wanted.
Response options range from 1 (none of the time) to 5 (all of the time).
Higher scores indicate greater social support.
|
8-week follow-up and 12-week follow-up
|
|
5-item 5-level EuroQol Group (EQ-5D-5L)
Time Frame: 8-week follow-up and 12-week follow-up
|
This 5-item measure assesses health-related quality of life across 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
The response options range from 1 to 5, with response choices that vary per question.
Higher scores indicate worse health-related quality of life.
|
8-week follow-up and 12-week follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
All-cause medical resource use
Time Frame: Baseline, 8-week follow-up, and 12-week follow-up
|
Participants will report their medical resource use.
This will include the number of hospitalizations and visits to the emergency department, urgent care, and outpatient clinics and current pain medication prescriptions.
These variables will be collected for the past 30 days at baseline and since the previous time point at both follow-ups.
|
Baseline, 8-week follow-up, and 12-week follow-up
|
|
Participant time
Time Frame: 8-week follow-up
|
The total number of minutes for each intervention session will be assessed.
|
8-week follow-up
|
|
Participant productivity
Time Frame: Baseline, 8-week follow-up, and 12-week follow-up
|
Participants' will report the number of weekly hours they worked inside and outside of the home.
|
Baseline, 8-week follow-up, and 12-week follow-up
|
|
Therapist time
Time Frame: 8-week follow-up
|
The total number of minutes that therapists spent preparing for, conducting, and documenting intervention sessions will be assessed.
|
8-week follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Joseph G Winger, PhD, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00110762
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
noiVita SrlsUniversity of Eastern PiedmontCompletedCervical Pain | Pain Management | Lumbar Pain | Muscular | Chronic Pain (Back / Neck)Italy
-
Chinese University of Hong KongNot yet recruitingPain, Acute | Chronic Post Operative Pain | Pain, ChronicHong Kong
-
University of SaskatchewanRoyal University Hospital FoundationCompletedPain | Pain, Acute | Pain, Chronic | Pain, IntractableCanada
-
Kyowa Kirin Co., Ltd.Completed
Clinical Trials on Meaning-Centered Pain Coping Skills Training
-
Duke UniversityIcahn School of Medicine at Mount SinaiCompleted
-
Duke UniversityCompleted
-
Duke UniversityCompletedPCST-Full (Pain Coping Skills Training) | PCST-BriefUnited States
-
Dokuz Eylul UniversityCompleted
-
Duke UniversityCompletedMobile Pain Coping Skills Training | In Person Pain Coping Skills TrainingUnited States
-
Duke UniversityNational Institute on Aging (NIA)Recruiting
-
University of North Carolina, Chapel HillPatient-Centered Outcomes Research InstituteCompletedOsteoarthritisUnited States
-
Duke UniversityCompletedBreast CancerUnited States
-
Wake Forest University Health SciencesHonorHealth Research InstituteWithdrawnCIPN - Chemotherapy-Induced Peripheral NeuropathyUnited States